SCHEMBL1010138

SCHEMBL1010138

Cc1nc(Cc2ccc(N)cc2)nc(N2CCCC2)c1C(C)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 1/20 0.40
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
EGLN1 Q9GZT9 2/20 0.36
HTR6 P50406 2/20 0.34
HRH4 Q9H3N8 1/20 0.34
ALDH1A1 P00352 3/20 0.34
CYP1A2 P05177 2/20 0.33
PPID Q08752 1/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33
CASP1 P29466 1/20 0.33
BRCA1 P38398 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1010248 0.85 CASP1 (0.38) CHRM3PDE4APDE4BPDE4CPDE4D
SCHEMBL3443370 0.80 CHRM3 (0.41) CHRM3PDE4APDE4BPDE4CPDE4D
SCHEMBL1009820 0.78 RAB9A (0.52) MEN1KMT2A
SCHEMBL12569066 0.75 TLR7 (0.41) CHRM3PDE4APDE4BPDE4CPDE4D
SCHEMBL1009043 0.74 COPS5 (0.40) EGLN1ALDH1A1MEN1KMT2ALMNA
SCHEMBL1924122 0.72 TBXA2R (0.38) EGLN1ALDH1A1LMNATSHRTRPV1
SCHEMBL1010222 0.72 TBXA2R (0.38) EGLN1ALDH1A1LMNATSHRTRPV1
SCHEMBL3443799 0.66 PTGDR2 (0.42) CHRM3PDE4APDE4BPDE4CPDE4D
SCHEMBL1010021 0.65 RAB9A (0.42) EGLN1ALDH1A1MEN1KMT2AKDM4E
SCHEMBL5026855 0.64 CHRM3 (0.50) CHRM3PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960393-B2 Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2 ACTIMIS PHARMACEUTICALS, INC. (US) 2011-06-14 US disclosed
EP-1633726-B1 PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASES MEDIATED BY CRTH2 ACTIMIS PHARMACEUTICALS INC (US) 2011-01-05 EP disclosed